Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone1-855-279-4652
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$215.10 million
Profitability
Miscellaneous
Employees2,779
Next Earnings Date11/11/2019 (Estimated)
OptionableOptionable
Aurora Cannabis (NYSE:ACB) Frequently Asked Questions
What is Aurora Cannabis' stock symbol?
Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."
When is Aurora Cannabis' next earnings date?
What guidance has Aurora Cannabis issued on next quarter's earnings?
Aurora Cannabis issued an update on its fourth quarter 2019 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $76-81.32 million.
What price target have analysts set for ACB?
13 brokerages have issued twelve-month price targets for Aurora Cannabis' stock. Their forecasts range from $5.00 to $13.50. On average, they expect Aurora Cannabis' share price to reach $8.04 in the next twelve months. This suggests a possible upside of 118.4% from the stock's current price. View Analyst Price Targets for Aurora Cannabis.
What is the consensus analysts' recommendation for Aurora Cannabis?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aurora Cannabis.
Has Aurora Cannabis been receiving favorable news coverage?
Media stories about ACB stock have trended negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Aurora Cannabis earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Aurora Cannabis.
Are investors shorting Aurora Cannabis?
Aurora Cannabis saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 153,030,000 shares, an increase of 15.1% from the August 30th total of 132,920,000 shares. Based on an average trading volume of 14,700,000 shares, the short-interest ratio is currently 10.4 days. Approximately 15.5% of the shares of the stock are sold short. View Aurora Cannabis' Current Options Chain.
Who are some of Aurora Cannabis' key competitors?
Some companies that are related to Aurora Cannabis include Canopy Growth (CGC), STADA Arzneimittel (STDAF), Cronos Group (CRON), Tilray (TLRY), USANA Health Sciences (USNA), Sundial Growers (SNDL), Canopy Rivers (RIV), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), True Drinks (TRUU), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN) and FitLife Brands (FTLF).
What other stocks do shareholders of Aurora Cannabis own?
Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the folowing people:
- Mr. Michael Singer, Exec. Chairman (Age 54)
- Mr. Terry Booth, Founder, CEO & Director (Age 54)
- Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
- Mr. Glen Ibbott, Chief Financial Officer
- Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer
Who are Aurora Cannabis' major shareholders?
Aurora Cannabis' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Truvestments Capital LLC (0.00%), TRUE Private Wealth Advisors (0.00%), Centric Wealth Management (0.00%) and Nachman Norwood & Parrott Inc (0.00%).
Which institutional investors are selling Aurora Cannabis stock?
ACB stock was sold by a variety of institutional investors in the last quarter, including Truvestments Capital LLC.
Which institutional investors are buying Aurora Cannabis stock?
ACB stock was purchased by a variety of institutional investors in the last quarter, including Centric Wealth Management, Nachman Norwood & Parrott Inc and TRUE Private Wealth Advisors.
How do I buy shares of Aurora Cannabis?
Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Aurora Cannabis' stock price today?
One share of ACB stock can currently be purchased for approximately $3.68.
How big of a company is Aurora Cannabis?
Aurora Cannabis has a market capitalization of $3.75 billion and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.View Additional Information About Aurora Cannabis.
What is Aurora Cannabis' official website?
How can I contact Aurora Cannabis?
Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]
MarketBeat Community Rating for Aurora Cannabis (NYSE ACB)
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
